Raised serum S100B protein levels in neuropsychiatric lupus

Annals of the Rheumatic Diseases

Volumn 65, Issue 6, 2006, Pages 829-831

  Schenatto, C B ^a   Xavier, R M ^a   Bredemeier, M ^a   Portela, L V C ^b   Tort, A B L ^b   Dedavid E Silva, T L ^a   Souza, D O ^b   Brenol, J C T ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPID ANTIBODY; PROTEIN S100B;

ADULT; ARTICLE; CEREBROVASCULAR DISEASE; CHOREA; CONTROLLED STUDY; CRANIAL NEUROPATHY; DEMENTIA; FEMALE; HUMAN; IMMUNOASSAY; KRUSKAL WALLIS TEST; LUMINESCENCE; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHIATRY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PSYCHOSIS; RANK SUM TEST; SEIZURE; STATISTICAL ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PROSPECTIVE STUDIES; ROC CURVE; S100 PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 33744455705     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.048330     Document Type: Article

References (15)

1. Rosner S, Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, et al. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum 1982;25:612-17.
2. Appenzeller S, Costallat LT. Primary central nervous system involvement in systemic lupus erythematosus. Revista Brasileira de Reumatologia 2003;43:20-5.
3. Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002;58:1214-20.
4. ACR. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
5. Bruyn GA. Controversies in lupus: nervous system involvement. Ann Rheum Dis 1995;54:159-67.
6. Heizmann CW. Ca2+-binding S100 proteins in the central nervous system. Neurochem Res 1999;24:1097-100.
7. Rothermundt M, Peters M, Prehn JH, Arolt V. S100B in brain damage and neurodegeneration. Microsc Res Tech 2003;60:614-32.
8. Portela LV, Brenol JC, Walz R, Bianchin M, Tort AB, Canabarro UP, et al. Serum S100B levels in patients with lupus erythematosus: preliminary observation. Clin Diagn Lab Immunol 2002;9:164-6.
9. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
10. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
11. Gorenstein C, Andrade L. Validation of a Portuguese version of the Beck Depression Inventory and the State-Trait Anxiety Inventory in Brazilian subjects. Braz J Med Biol Res 1996;29:453-7.
12. Bertolucci PH, Brucki SM, Campacci SR, Juliano Y. [The Mini-Mental State Examination in a general population: impact of educational status]. Arq Neuropsiquiatr 1994;52:1-7.
13. Lara DR, Gama CS, Belmonte-de-Abreu P, Portela LV, Goncalves CA, Fonseca M, et al. Increased serum S100B protein in schizophrenia: a study in medication-free patients. J Psychiatr Res 2001;35:11-14.
14. Zvaifler NJ, Bluestein HG. The pathogenesis of central nervous system manifestations of systemic lupus erythematosus. Arthritis Rheum 1982;25:862-6.
15. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001;7:1189-93.